Sterilex Corporation is a recognized leader in developing
antimicrobial, anti-biofilm, and decontamination products
for infection control, biofilm removal, biodecontamination,
and chemical decontamination. Sterilex specialty biofilm-control
biocides, disinfectants, and decontamination products
are used in a variety of applications including human
health, dental health, animal health, food processing,
water care, industrial processing, and environmental remediation.
Sterilex patented platform technology is based upon PerQuat™
technology, an alkaline peroxygen phase-transfer chemistry
which has the unique ability to penetrate and remove biofilms,
kill microorganisms in biofilms, and remove organic contaminants.
This chemistry is also effective in decontaminating chemical
contaminants including nerve agents, organophosphorus
pesticides, and carbamates. The efficacy of Sterilex products
is a result of multiple physical and chemical mechanisms
of action, including hydrolysis, oxidation, and a physical
“scrubbing” effect generated in situ. The combination
of physical and chemical mechanisms of action, leading
to physical removal of the biofilm as well as killing
of resident organisms, reduces the risk of microbial resistance
to Sterilex products.
The Sterilex platform PerQuat™ technology is
unique in its ability to rapidly penetrate and remove
microbial biofilms on surfaces, and to kill microorganisms
in biofilms. Microorganisms in biofilms are 1000-times
more resistant to antimicrobial attack compared to free-swmming,
or planktonic, bacteria. Other antimicrobial chemistries,
(most of which were developed prior to the discovery that
biofilms are the reservoir for bacteria), are designed
to kill free-swimming microorganisms, but are not optimized
to attack biofilm bacteria.
Sterilex is a woman-owned firm.
111 Lake Front Drive
Hunt Valley, MD 21030